Login
Home
Charts
Search
Watchlist
Products

Camson Bio Technologies Ltd

CAMSONBIO·BSE
3.310.00%Mon, 11 May '20

Camson Bio Technologies Ltd

CAMSONBIO
BSE
3.31
0.00%
|Mon, 11 May '20
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
10Cr
Close
Close Price
3.31
Industry
Industry
Floriculture/Tissue Culture
PE
Price To Earnings
PS
Price To Sales
2.03
Revenue
Revenue
5Cr
Rev Gr TTM
Revenue Growth TTM
-47.70%
PAT Gr TTM
PAT Growth TTM
-45.63%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Revenue
RevenueCr
2511154-112211
Growth YoY
Revenue Growth YoY%
-82.118.5120.3449.8114.6-28.6-144.7-88.5-67.7-59.0215.7-7.8
Expenses
ExpensesCr
51227552231157
Operating Profit
Operating ProfitCr
-3-6-140-1-3-1-10-15-6
OPM
OPM%
-136.7-117.8-51.337.0-3.8-25.4583.4-43.7-90.821.7-2,507.0-464.7
Other Income
Other IncomeCr
110110000210
Interest Expense
Interest ExpenseCr
1211130222-50
Depreciation
DepreciationCr
220222222222
PBT
PBTCr
-5-10-12-3-6-5-4-5-1-11-8
Tax
TaxCr
000000000-110
PAT
PATCr
-5-10-12-3-6-5-4-6-1-11-8
Growth YoY
PAT Growth YoY%
-768.34.195.3126.353.442.6-288.9-334.1-123.188.3-130.6-77.0
NPM
NPM%
-249.8-180.3-110.516.1-54.3-144.9960.8-330.2-374.3-41.1-1,915.3-633.6
EPS
EPS
-1.8-3.2-0.40.6-0.8-1.9-1.6-1.4-1.9-0.2-3.8-2.5
QuarterSep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Revenue
RevenueCr
2511154-112211
Growth YoY
Revenue Growth YoY%
-82.118.5120.3449.8114.6-28.6-144.7-88.5-67.7-59.0215.7-7.8
Expenses
ExpensesCr
51227552231157
Operating Profit
Operating ProfitCr
-3-6-140-1-3-1-10-15-6
OPM
OPM%
-136.7-117.8-51.337.0-3.8-25.4583.4-43.7-90.821.7-2,507.0-464.7
Other Income
Other IncomeCr
110110000210
Interest Expense
Interest ExpenseCr
1211130222-50
Depreciation
DepreciationCr
220222222222
PBT
PBTCr
-5-10-12-3-6-5-4-5-1-11-8
Tax
TaxCr
000000000-110
PAT
PATCr
-5-10-12-3-6-5-4-6-1-11-8
Growth YoY
PAT Growth YoY%
-768.34.195.3126.353.442.6-288.9-334.1-123.188.3-130.6-77.0
NPM
NPM%
-249.8-180.3-110.516.1-54.3-144.9960.8-330.2-374.3-41.1-1,915.3-633.6
EPS
EPS
-1.8-3.2-0.40.6-0.8-1.9-1.6-1.4-1.9-0.2-3.8-2.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Revenue
RevenueCr
9911212014616925101955
Growth
Revenue Growth%
13.76.621.816.3-85.0-59.386.6-74.2-47.7
Expenses
ExpensesCr
7690911211534024192126
Operating Profit
Operating ProfitCr
2322282516-14-130-16-21
OPM
OPM%
22.819.623.616.99.5-56.6-127.70.2-329.4-437.7
Other Income
Other IncomeCr
100-3614133
Interest Expense
Interest ExpenseCr
0024457510
Depreciation
DepreciationCr
123513227777
PBT
PBTCr
222023135-40-23-11-21-25
Tax
TaxCr
000-12-20010
PAT
PATCr
222123133-38-23-11-22-25
Growth
PAT Growth%
-5.811.0-42.3-76.8-1,327.539.151.3-95.2-45.6
NPM
NPM%
22.318.519.29.11.8-148.9-222.7-58.1-440.0-516.0
EPS
EPS
12.111.412.75.31.1-12.6-7.6-3.7-7.3-8.4
Financial YearMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Revenue
RevenueCr
9911212014616925101955
Growth
Revenue Growth%
13.76.621.816.3-85.0-59.386.6-74.2-47.7
Expenses
ExpensesCr
7690911211534024192126
Operating Profit
Operating ProfitCr
2322282516-14-130-16-21
OPM
OPM%
22.819.623.616.99.5-56.6-127.70.2-329.4-437.7
Other Income
Other IncomeCr
100-3614133
Interest Expense
Interest ExpenseCr
0024457510
Depreciation
DepreciationCr
123513227777
PBT
PBTCr
222023135-40-23-11-21-25
Tax
TaxCr
000-12-20010
PAT
PATCr
222123133-38-23-11-22-25
Growth
PAT Growth%
-5.811.0-42.3-76.8-1,327.539.151.3-95.2-45.6
NPM
NPM%
22.318.519.29.11.8-148.9-222.7-58.1-440.0-516.0
EPS
EPS
12.111.412.75.31.1-12.6-7.6-3.7-7.3-8.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Equity Capital
Equity CapitalCr
181818253030303030
Reserves
ReservesCr
8710712817923474473715
Current Liabilities
Current LiabilitiesCr
232237415155596364
Non Current Liabilities
Non Current LiabilitiesCr
1519141012111213
Total Liabilities
Total LiabilitiesCr
131153217282325172147142122
Current Assets
Current AssetsCr
939011413117927174735
Non Current Assets
Non Current AssetsCr
38631021521461451309587
Total Assets
Total AssetsCr
131153217282325172147142122
Financial YearMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Equity Capital
Equity CapitalCr
181818253030303030
Reserves
ReservesCr
8710712817923474473715
Current Liabilities
Current LiabilitiesCr
232237415155596364
Non Current Liabilities
Non Current LiabilitiesCr
1519141012111213
Total Liabilities
Total LiabilitiesCr
131153217282325172147142122
Current Assets
Current AssetsCr
939011413117927174735
Non Current Assets
Non Current AssetsCr
38631021521461451309587
Total Assets
Total AssetsCr
131153217282325172147142122

Cash Flow

Consolidated
Standalone
Financial YearMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Operating Cash Flow
Operating Cash FlowCr
-210-13-1514-10520
Investing Cash Flow
Investing Cash FlowCr
-21-20-25-36-435310
Financing Cash Flow
Financing Cash FlowCr
1093951284-7-30
Net Cash Flow
Net Cash FlowCr
-13-110-10000
Free Cash Flow
Free Cash FlowCr
-19-10-39-51-301710
CFO To PAT
CFO To PAT%
-8.449.0-58.6-110.5443.426.4-19.8-16.30.0
CFO To EBITDA
CFO To EBITDA%
-8.246.2-47.9-59.485.169.5-34.55,305.80.0
Financial YearMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Operating Cash Flow
Operating Cash FlowCr
-210-13-1514-10520
Investing Cash Flow
Investing Cash FlowCr
-21-20-25-36-435310
Financing Cash Flow
Financing Cash FlowCr
1093951284-7-30
Net Cash Flow
Net Cash FlowCr
-13-110-10000
Free Cash Flow
Free Cash FlowCr
-19-10-39-51-301710
CFO To PAT
CFO To PAT%
-8.449.0-58.6-110.5443.426.4-19.8-16.30.0
CFO To EBITDA
CFO To EBITDA%
-8.246.2-47.9-59.485.169.5-34.55,305.80.0

Ratios

Consolidated
Standalone
Financial YearMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
210898114128110552462110
Price To Earnings
Price To Earnings
9.74.43.611.090.9
Price To Sales
Price To Sales
2.10.80.71.01.74.25.02.44.22.0
Price To Book
Price To Book
2.00.70.60.71.11.00.70.70.50.2
EV To EBITDA
EV To EBITDA
9.34.64.27.119.7-10.6-7.42,736.7-4.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
76.560.452.050.247.251.053.052.5-217.8-217.8
OPM
OPM%
22.819.623.616.99.5-56.6-127.70.2-329.4-437.7
NPM
NPM%
22.318.519.29.11.8-148.9-222.7-58.1-440.0-516.0
ROCE
ROCE%
21.315.113.66.93.0-23.1-13.6-5.1-21.3-21.3
ROE
ROE%
21.016.515.76.51.2-36.3-29.9-16.8-48.9-48.9
ROA
ROA%
16.813.510.64.70.9-22.0-15.7-7.9-17.9-17.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
210898114128110552462110
Price To Earnings
Price To Earnings
9.74.43.611.090.9
Price To Sales
Price To Sales
2.10.80.71.01.74.25.02.44.22.0
Price To Book
Price To Book
2.00.70.60.71.11.00.70.70.50.2
EV To EBITDA
EV To EBITDA
9.34.64.27.119.7-10.6-7.42,736.7-4.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
76.560.452.050.247.251.053.052.5-217.8-217.8
OPM
OPM%
22.819.623.616.99.5-56.6-127.70.2-329.4-437.7
NPM
NPM%
22.318.519.29.11.8-148.9-222.7-58.1-440.0-516.0
ROCE
ROCE%
21.315.113.66.93.0-23.1-13.6-5.1-21.3-21.3
ROE
ROE%
21.016.515.76.51.2-36.3-29.9-16.8-48.9-48.9
ROA
ROA%
16.813.510.64.70.9-22.0-15.7-7.9-17.9-17.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios